PMID: 15240970Jul 9, 2004Paper

Prothrombin 20210GA and factor V Leiden mutations in patients less than 55 years old with myocardial infarction

Japanese Heart Journal
Yurdaer DönmezFikri Baslamisli

Abstract

Several studies claim that prothrombin 20210GA and factor V Leiden mutations are related to arterial thrombosis. We investigated the frequencies of these mutations and their significance in the development of early atherosclerosis in acute myocardial infarction (AMI) patients younger than 55 years of age. We investigated 96 patients with AMI and 77 control subjects. The diagnosis of AMI was established by typical chest pain and ST elevations on the presentation electrocardiogram and characteristic cardiac enzyme elevations. None of the control subjects had evidence of cardiovascular disease. DNA samples were isolated from all subjects and prothrombin 20210GA and factor V Leiden mutations were determined by the RealTime PCR technique with the aid of a Light Cycler device. The prevalence of factor V Leiden mutation was 6.3% and 5.2% in the patient and control groups, respectively (OR 0.6 [95% CI 0.1- 3.9], P = 0.6), whereas the prevalence of prothrombin G20210A mutation was 4.2% and 2.6% in the patient and control groups, respectively (OR 2.8 [95% CI 0.2 - 32.2], P = 0.4). None of the patients had both mutations. Prothrombin 20210GA and factor V Leiden mutations are not significant risk factors for the development of myocardial i...Continue Reading

References

Oct 28, 1995·Lancet·D C ReesJ B Clegg
Feb 24, 1995·The Journal of Biological Chemistry·M KalafatisK G Mann
Apr 23, 1997·JAMA : the Journal of the American Medical Association·P M RidkerJ E Buring
Jan 24, 1998·American Journal of Medical Genetics·J P GreggW W Grody
Oct 8, 1998·Seminars in Thrombosis and Hemostasis·V De StefanoG Leone
May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults

❮ Previous
Next ❯

Citations

Mar 6, 2007·Journal of Thrombosis and Thrombolysis·Fuat GundogduHuseyin Senocak
Feb 26, 2013·Archivos de cardiología de México·Luis Miguel Canseco-ÁvilaAugusto Rojas-Martínez
Jan 13, 2005·American Heart Journal·Maichi Tran, Frederick A Spencer
Feb 20, 2015·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Wael AlkhiarySolafa El-Sharawy
Jul 4, 2012·Annals of Saudi Medicine·Najiba Fekih-MrissaNasreddine Gritli
Jul 17, 2009·Genetic Testing and Molecular Biomarkers·Carolina I PestanaAntonietta Porco
Jul 21, 2010·Genetic Testing and Molecular Biomarkers·Moataz Dowaidar, Ahmad Settin
Sep 22, 2006·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Meral KayikciogluCan Hasdemir
May 5, 2005·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Meral KaykçoğluCuneyt Turkoglu
Nov 6, 2007·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·H Yekta GurlertopHuseyin Senocak
Dec 29, 2011·Molecular Biology Reports·Oguzhan YucelSinasi Manduz
Jan 23, 2013·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Tathagata ChatterjeeMohammad Z Ashraf
Mar 28, 2019·Circulation·Jacqueline E Tamis-HollandUNKNOWN American Heart Association Interventional Cardiovascular Care Committee of the Council on Clinical Cardiology; Council on Ca
Nov 17, 2010·Molecular Biology Reports·Sulhattin ArslanIbrahim Akkurt

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.